Article

Dr. Shore Provides an Overview of Biomarkers in Prostate Cancer

Author(s):

Neal D. Shore, MD, FACS

Neal D. Shore, MD, FACS, medical director, Carolina Urologic Research Center, provides an overview of biomarkers in prostate cancer.

Neal D. Shore, MD, FACS, medical director, Carolina Urologic Research Center, provides an overview of biomarkers in prostate cancer.

“The field of biomarkers in prostate cancer is exploding exponentially, and it has been for some time now,” Shore says. “The challenge is that most of the biomarkers that are commercially available are not reimbursed and, some might argue, are truly not yet ready for primetime.”

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Personalized Therapy Helps Tailor Treatment for GIST
Image of two doctors with text.
Can ctDNA Help Guide Surgical Decision Making in Breast Cancer
Image of doctors with text.
Experts Walk Through Recent Hematologic Malignancy Treatment Updates
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Zanzalintinib Triplet Combo Under Investigation in Kidney Cancer Subgroups
Image of two doctors and text.
New Treatment Options Emerging for Across Lung Cancer Subtypes
Image of patient and doctor.
Understanding the Whole Person Behind their Cancer Diagnosis
Image of two doctors with text.
Delving Into Brain Cancer Treatment Takeaways Following ASCO 2025
image of gerds
Breaking Down the VERIFY Trial for Patients With Polycythemia Vera
Image of 2 doctors and text.
What Should Patients With Lung Cancer Know After ASCO 2025?
Image of two doctors and text.
Bringing Light to More Personalized Medicine in Lung Cancer After ASCO 2025
Related Content
Image of smiley face.
June 20th 2025

Radiation and Resilience: Laughing Through the Hardest Days

Dave Davison
It’s a bad day when a doctor says you have cancer. It’s a worse day when he says it’s stage prostate cancer with a metastatic lesion.
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
January 30th 2024

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
Surgery and radiation yield similar cancer outcomes for low-risk prostate cancer: © stock.adobe.com.
June 13th 2025

Similar Outcomes Yielded Between Surgery and Radiation in Low-Risk Prostate Cancer

Spencer Feldman
Surgery and radiation yield similar cancer outcomes for low-risk prostate cancer, but higher-risk cases may require combining treatments, experts said.
CURE Cancer Horizons podcast logo
January 29th 2024

Prostate Cancer Headlines, CAR-T Warnings and Laughter Therapy

Alex Biese Brielle Benyon
CURE® editors discuss last week’s biggest cancer headlines, from Dexter Scott King’s death to the potential of laughter therapy to boost quality of life.
Image of bottle
June 6th 2025

Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation

Roman Fabbricatore
Adding Zyprexa to ondansetron cut nausea and vomiting safely in abdominal/pelvic radiation with low-emetogenic capecitabine.
Dr. Alicia Morgans discussed complications associated with androgen deprivation therapy in prostate cancer: © stock.adobe.com.
June 4th 2025

Addressing Complications from ADT Therapy to Treat Prostate Cancer

Kristie L. Kahl
Dr. Alicia Morgans discussed complications associated with ADT in prostate cancer, and how men can still maintain quality of life regardless.